Skip to main content
. 2019 Feb;64:28–36. doi: 10.1016/j.medengphy.2018.12.011

Fig. 12.

Fig. 12

Dose-volume histograms for (a) prostate A, (b) prostate B, (c) lung, (d) liver and (e) partial breast cases. Dotted lines: body path (110 nodes), dashed lines: preset short path (36 nodes), solid lines: BOS path (15 nodes). The principal dose constraints are shown as points. The PTV constraints in (b) are all minimum dose constraints.